Oxford BioMedica Company
Oxford BioMedica is a pioneer of gene and cell therapy, with a leading industry position in lentiviral vector and cell therapy research.
Technology:
AgeTech Companies, CAR-T therapy
Industry:
Healthcare, Public
Headquarters:
Oxford, Oxfordshire, United Kingdom
Founded Date:
1995-01-01
Employees Number:
501-1000
Funding Status:
M&A
Investors Number:
3
Total Funding:
62300000
Estimated Revenue:
$10M to $50M
Last Funding Date:
2021-09-22
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership